EnteroMedics' Unattributed VC Round

EnteroMedics raised a round of funding on October 20, 2003. Investors include Venturi Group.

EnteroMedics (NASDAQ: ETRM) has developed vBloc® vagal blocking therapy, a unique, broadly patented therapeutic approach to treat a range of gastrointestinal and metabolic diseases. vBloc® is a firs…

Articles about EnteroMedics' Unattributed VC Round: